Literature DB >> 7935046

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis.

T Uchida1, M Shimojima, K Gotoh, T Shikata, E Tanaka, K Kiyosawa.   

Abstract

Since the recent introduction of diagnostic kits for hepatitis C and E, some cases of non-A, non-B, non-C, non-D, non-E hepatitis (so-called hepatitis F) have been revealed. We attempted to demonstrate that so-called hepatitis F is caused by hepatitis B virus (HBV) variants. Polymerase chain reaction (PCR) was used to amplify serum HBV DNAs from 20 patients with acute hepatitis and 20 patients with chronic hepatitis who had been diagnosed as having so-called hepatitis F on the basis of conventional serological markers. The PCR technique successfully amplified HBV DNAs in 18 (90%) cases of acute hepatitis and 17 (85%) cases of chronic hepatitis. Sequencing of HBV DNAs of six patients (acute 3, chronic 3) revealed equally a T-to-C mutation of DR2 and an 8-nucleotide deletion of the 3'-terminus of the X gene coding region, giving rise to the generation of a C-terminally truncated X protein and probable damage to the enhancer II/core promoter elements. These mutations of the X gene coding region may lead to suppression of replication and expression of HBV DNAs. Thus virtually all cases of so-called hepatitis F appear to be caused by "silent" HBV mutants, at least in Japan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935046     DOI: 10.1111/j.1348-0421.1994.tb01777.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  4 in total

1.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Authors:  S Günther; N Piwon; A Iwanska; R Schilling; H Meisel; H Will
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

2.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology.

Authors:  C Berasain; M Betés; A Panizo; J Ruiz; J I Herrero; M P Civeira; J Prieto
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

3.  Cryptogenic cirrhosis in the region where obesity is not prevalent.

Authors:  Hideyuki Kojima; Shinya Sakurai; Masahiko Matsumura; Norie Umemoto; Masahito Uemura; Hiroyo Morimoto; Yasuhiro Tamagawa; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

4.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.